Found: 12
Select item for more details and to access through your institution.
Early Video-assisted Thoracoscopic Surgery or Intrapleural Enzyme Therapy in Pleural Infection: A Feasibility Randomized Controlled Trial. The Third Multicenter Intrapleural Sepsis Trial--MIST-3.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 12, p. 1305, doi. 10.1164/rccm.202305-0854OC
- By:
- Publication type:
- Article
Early Video Assisted Thoracoscopic Surgery (VATS) or Intrapleural Enzyme Therapy (IET) in Pleural Infection -- a feasibility randomized controlled trial (The third Multicenter Intrapleural Sepsis Trial - MIST-3).
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 12, p. E1, doi. 10.1164/rccm.202305-0854oc
- By:
- Publication type:
- Article
The Prevalence and Clinical Relevance of Nonexpandable Lung in Malignant Pleural Mesothelioma. A Prospective, Single-Center Cohort Study of 229 Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Local Anaesthetic (Medical) Thoracoscopy Services in the UK.
- Published in:
- Respiration, 2018, v. 96, n. 6, p. 560, doi. 10.1159/000491674
- By:
- Publication type:
- Article
Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma.
- Published in:
- BMC Pulmonary Medicine, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12890-022-01968-2
- By:
- Publication type:
- Article
Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study.
- Published in:
- BMC Palliative Care, 2017, v. 16, p. 1, doi. 10.1186/s12904-017-0255-3
- By:
- Publication type:
- Article
Interpretation of pleural fluid biochemistry.
- Published in:
- British Journal of Hospital Medicine (17508460), 2016, v. 77, n. 9, p. C149, doi. 10.12968/hmed.2016.77.9.C149
- By:
- Publication type:
- Article
Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.
- Published in:
- 2017
- By:
- Publication type:
- journal article